Antimicrobial resistance in liver disease: better diagnostics are needed

High rates of SARS-CoV-2 reinfection in residents of long term care facilities despite robust spike-specific immunity following serial vaccination.

PloS one·2026

Making microbes matter: evidence for the use of digital storytelling in antimicrobial resistance public engagement.

npj antimicrobials and resistance·2026

Serum SOS1 as a prognostic biomarker and therapeutic target for progressive liver disease.

iScience·2026

Implementation of the VIVALDI Social Care data pipeline for monitoring and research of infections in care homes for older adults in the UK.

International journal of medical informatics·2026

Asymptomatic testing compared with standard care of the care home staff in shaping care home COVID-19 testing policy: the VIVALDI-CT pragmatic cluster RCT (VIVALDI-CT).

Health and social care delivery research·2026

A systematic review and meta-analysis of the use of human albumin solution for treating the complications of liver cirrhosis.

Hepatology communications·2026

The trajectory of inflammatory bowel disease in east and southeast Asia: transitioning from acceleration in incidence to compounding prevalence.

The lancet. Gastroenterology & hepatology·2026

A blood-based test for detection of advanced adenomas and colorectal cancer (DENEB): a multicentre diagnostic accuracy study.

The lancet. Gastroenterology & hepatology·2026

The glucagon and GLP-1 receptor dual agonist DD01 for metabolic dysfunction-associated steatotic liver disease and steatohepatitis (DD01-DN-02): 12-week results from a randomised, double-blind, multicentre, placebo-controlled, phase 2 trial.

The lancet. Gastroenterology & hepatology·2026

Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial.

The lancet. Gastroenterology & hepatology·2026

Adaptation of the molecular bacterial load assay for real-time quantification of Mycobacterium tuberculosis in the clinical routine laboratory.

Microbiology spectrum·2026

Prevalence of antimicrobial resistance in acute community-acquired urinary tract infections in Sub-Saharan Africa: a systematic review.

JAC-antimicrobial resistance·2026

Antibacterial Immunotherapy: Mechanistic Insights, Emerging Therapeutic Strategies, and Clinical Translation.

Infection and drug resistance·2026

Species Diversity of Nontuberculous Mycobacteria in Dental Unit Waterlines: Implications for Infection Control and Clinical Practice.

Infection and drug resistance·2026

When might we consider using the newer β-lactam agents as empirical therapy against presumed carbapenem-resistant gram-negative infections?

JAC-antimicrobial resistance·2026

Integrated computational and experimental evaluation of natural products targeting PGM/AlgC and HisIE in multidrug-resistant respiratory pathogens.

Frontiers in microbiology·2026

Related Experiment Videos

Antimicrobial resistance in liver disease: better diagnostics are needed

Related Concept Videos

High rates of SARS-CoV-2 reinfection in residents of long term care facilities despite robust spike-specific immunity following serial vaccination.

Making microbes matter: evidence for the use of digital storytelling in antimicrobial resistance public engagement.

Serum SOS1 as a prognostic biomarker and therapeutic target for progressive liver disease.

Implementation of the VIVALDI Social Care data pipeline for monitoring and research of infections in care homes for older adults in the UK.

Asymptomatic testing compared with standard care of the care home staff in shaping care home COVID-19 testing policy: the VIVALDI-CT pragmatic cluster RCT (VIVALDI-CT).

A systematic review and meta-analysis of the use of human albumin solution for treating the complications of liver cirrhosis.

The trajectory of inflammatory bowel disease in east and southeast Asia: transitioning from acceleration in incidence to compounding prevalence.

A blood-based test for detection of advanced adenomas and colorectal cancer (DENEB): a multicentre diagnostic accuracy study.

The glucagon and GLP-1 receptor dual agonist DD01 for metabolic dysfunction-associated steatotic liver disease and steatohepatitis (DD01-DN-02): 12-week results from a randomised, double-blind, multicentre, placebo-controlled, phase 2 trial.

Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial.

Adaptation of the molecular bacterial load assay for real-time quantification of Mycobacterium tuberculosis in the clinical routine laboratory.

Prevalence of antimicrobial resistance in acute community-acquired urinary tract infections in Sub-Saharan Africa: a systematic review.

Antibacterial Immunotherapy: Mechanistic Insights, Emerging Therapeutic Strategies, and Clinical Translation.

Species Diversity of Nontuberculous Mycobacteria in Dental Unit Waterlines: Implications for Infection Control and Clinical Practice.

When might we consider using the newer β-lactam agents as empirical therapy against presumed carbapenem-resistant gram-negative infections?

Integrated computational and experimental evaluation of natural products targeting PGM/AlgC and HisIE in multidrug-resistant respiratory pathogens.

Related Experiment Videos

Antimicrobial resistance in liver disease: better diagnostics are needed

Related Concept Videos

Related Articles